GlassScriptPhysician profile
Paige Ward
NPI 1649381575
$853.46
in general payments reported to CMS, 2019-2025
19 companies · $162 in 2025
The $162 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $88.30 · 2021: $90.03 · 2022: $11.89 · 2023: $182 · 2024: $183 · 2025: $162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $527.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $192.51 | 2023-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $131.15 | 2019-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $102.87 | 2021-2025 | Qelbree, Qelbree |
| Novo Nordisk INC | $82.48 | 2023-2024 | Wegovy |
| Pfizer INC. | $61.55 | 2019-2021 | |
| Glaxosmithkline, LLC. | $44.94 | 2021-2025 | Arexvy, Shingrix, Penmenvy |
| Sanofi Pasteur INC. | $31.24 | 2019-2024 | |
| Sobi, INC | $24.14 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $21.48 | 2025 | Rexulti |
| Seqirus USA INC | $20.78 | 2023 | Flucelvax Quadrivalent |
| Abbvie INC. | $19.49 | 2024 | |
| Cranial Technologies, INC | $18.33 | 2020 | |
| 180 Medical, INC. | $16.88 | 2019 | |
| Collegium Pharmaceutical, INC. | $16.57 | 2025 | Jornay Pm |
| Kaleo, INC. | $15.36 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $14.60 | 2020 | |
| Genentech USA, INC. | $13.26 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.23 | 2020 | |
| Merck Sharp & Dohme LLC | $12.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paige Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.